BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35629940)

  • 1. Salivary Metabolomics for Oral Cancer Detection: A Narrative Review.
    Panneerselvam K; Ishikawa S; Krishnan R; Sugimoto M
    Metabolites; 2022 May; 12(5):. PubMed ID: 35629940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary metabolomics for cancer detection.
    Sugimoto M
    Expert Rev Proteomics; 2020 Sep; 17(9):639-648. PubMed ID: 33140667
    [No Abstract]   [Full Text] [Related]  

  • 3. Updates and Original Case Studies Focused on the NMR-Linked Metabolomics Analysis of Human Oral Fluids Part III: Implementations for the Diagnosis of Non-Cancerous Disorders, Both Oral and Systemic.
    Grootveld M; Page G; Bhogadia M; Hunwin K; Edgar M
    Metabolites; 2023 Jan; 13(1):. PubMed ID: 36676991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Salivary Biomarkers in Oral Cancer Detection.
    Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
    Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment.
    Zhang A; Sun H; Wang X
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1718-27. PubMed ID: 22971835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging technologies for salivaomics in cancer detection.
    Kaczor-Urbanowicz KE; Martín Carreras-Presas C; Kaczor T; Tu M; Wei F; Garcia-Godoy F; Wong DT
    J Cell Mol Med; 2017 Apr; 21(4):640-647. PubMed ID: 27862926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary Metabolomics: From Diagnostic Biomarker Discovery to Investigating Biological Function.
    Gardner A; Carpenter G; So PW
    Metabolites; 2020 Jan; 10(2):. PubMed ID: 31991929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates and Original Case Studies Focused on the NMR-Linked Metabolomics Analysis of Human Oral Fluids Part II: Applications to the Diagnosis and Prognostic Monitoring of Oral and Systemic Cancers.
    Grootveld M; Percival BC; Page G; Hunwin K; Bhogadia M; Chan W; Edgar M
    Metabolites; 2022 Aug; 12(9):. PubMed ID: 36144183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary Metabolomics for Diagnosis and Monitoring Diseases: Challenges and Possibilities.
    Hyvärinen E; Savolainen M; Mikkonen JJW; Kullaa AM
    Metabolites; 2021 Aug; 11(9):. PubMed ID: 34564402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of timing of collection of salivary metabolomic biomarkers on oral cancer detection.
    Ishikawa S; Sugimoto M; Kitabatake K; Tu M; Sugano A; Yamamori I; Iba A; Yusa K; Kaneko M; Ota S; Hiwatari K; Enomoto A; Masaru T; Iino M
    Amino Acids; 2017 Apr; 49(4):761-770. PubMed ID: 28101653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Saliva Metabolome for Oral Lichen Planus Biomarker Identification.
    Wang X; Liu L; Du Q; Sun Z; Yue E; Xue P; Zhao H
    Recent Pat Anticancer Drug Discov; 2021; 16(3):417-425. PubMed ID: 33655848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical analysis of oral fluids for disease detection.
    Khurshid Z; Warsi I; Moin SF; Slowey PD; Latif M; Zohaib S; Zafar MS
    Adv Clin Chem; 2021; 100():205-253. PubMed ID: 33453866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva diagnostics - Current views and directions.
    Kaczor-Urbanowicz KE; Martin Carreras-Presas C; Aro K; Tu M; Garcia-Godoy F; Wong DT
    Exp Biol Med (Maywood); 2017 Mar; 242(5):459-472. PubMed ID: 27903834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancies and Biosensors: A Focus on Oral Cancer Detection through Salivary Biomarkers.
    Goldoni R; Scolaro A; Boccalari E; Dolci C; Scarano A; Inchingolo F; Ravazzani P; Muti P; Tartaglia G
    Biosensors (Basel); 2021 Oct; 11(10):. PubMed ID: 34677352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary metabolomics with alternative decision tree-based machine learning methods for breast cancer discrimination.
    Murata T; Yanagisawa T; Kurihara T; Kaneko M; Ota S; Enomoto A; Tomita M; Sugimoto M; Sunamura M; Hayashida T; Kitagawa Y; Jinno H
    Breast Cancer Res Treat; 2019 Oct; 177(3):591-601. PubMed ID: 31286302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary metabolomics in the diagnosis of oral cancer and periodontal diseases.
    Mikkonen JJ; Singh SP; Herrala M; Lappalainen R; Myllymaa S; Kullaa AM
    J Periodontal Res; 2016 Aug; 51(4):431-7. PubMed ID: 26446036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles.
    Sugimoto M; Wong DT; Hirayama A; Soga T; Tomita M
    Metabolomics; 2010 Mar; 6(1):78-95. PubMed ID: 20300169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary metabolite signatures of oral cancer and leukoplakia.
    Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
    Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary Metabolomics for Systemic Cancer Diagnosis: A Systematic Review.
    Nijakowski K; Zdrojewski J; Nowak M; Gruszczyński D; Knoll F; Surdacka A
    Metabolites; 2022 Dec; 13(1):. PubMed ID: 36676953
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.